{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:00:03Z","timestamp":1785272403763,"version":"3.55.0"},"reference-count":46,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,1,29]]},"published-print":{"date-parts":[[2026,6]]},"DOI":"10.2967\/jnumed.125.270922","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:45:13Z","timestamp":1773341113000},"page":"878-886","source":"Crossref","is-referenced-by-count":1,"title":["PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer"],"prefix":"10.2967","volume":"67","author":[{"given":"Julia","family":"Hbart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Da Pieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Raes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Borys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Maczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitanjali","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Melcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Kramer-Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"2026060105301033000_67.6.878.1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"2026060105301033000_67.6.878.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.03.001"},{"key":"2026060105301033000_67.6.878.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7"},{"key":"2026060105301033000_67.6.878.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"2026060105301033000_67.6.878.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-021-00131-7"},{"key":"2026060105301033000_67.6.878.6","doi-asserted-by":"crossref","first-page":"e89829","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight."},{"key":"2026060105301033000_67.6.878.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abk3436"},{"key":"2026060105301033000_67.6.878.8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/14712598.2020.1729351","article-title":"Combination therapy with oncolytic viruses and immune checkpoint inhibitors","volume":"20","author":"Chiu","year":"2020","journal-title":"Expert Opin Biol Ther."},{"key":"2026060105301033000_67.6.878.9","unstructured":"Samson A Scott KJ Taggart D . Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Sci Transl Med. 2018;10"},{"key":"2026060105301033000_67.6.878.10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14754"},{"key":"2026060105301033000_67.6.878.11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax7992"},{"key":"2026060105301033000_67.6.878.12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.272"},{"key":"2026060105301033000_67.6.878.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-652503"},{"key":"2026060105301033000_67.6.878.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0468"},{"key":"2026060105301033000_67.6.878.15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2078"},{"key":"2026060105301033000_67.6.878.16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3377"},{"key":"2026060105301033000_67.6.878.17","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0682-1"},{"key":"2026060105301033000_67.6.878.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.014"},{"key":"2026060105301033000_67.6.878.19","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41591-018-0255-8","article-title":"Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer","volume":"24","author":"Bensch","year":"2018","journal-title":"Nat Med."},{"key":"2026060105301033000_67.6.878.20","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-018-07131-y","article-title":"Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer","volume":"9","author":"Niemeijer","year":"2018","journal-title":"Nat Commun."},{"key":"2026060105301033000_67.6.878.21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7143"},{"key":"2026060105301033000_67.6.878.22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3477"},{"key":"2026060105301033000_67.6.878.23","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000400"},{"key":"2026060105301033000_67.6.878.24","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1200\/JCO.2020.38.15_suppl.3573","article-title":"Zr-89-durvalumab PD-L1 PET in recurrent or metastatic (R\/M) squamous cell carcinoma of the head and neck [abstract]","volume":"38(suppl)","author":"Verhoeff","year":"2020","journal-title":"J Clin Oncol."},{"key":"2026060105301033000_67.6.878.25","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","article-title":"Standards for PET image acquisition and quantitative data analysis","volume":"50(suppl 1)","author":"Boellaard","year":"2009","journal-title":"J Nucl Med."},{"key":"2026060105301033000_67.6.878.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1899-5"},{"key":"2026060105301033000_67.6.878.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.01.015"},{"key":"2026060105301033000_67.6.878.28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0339"},{"key":"2026060105301033000_67.6.878.29","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191145"},{"key":"2026060105301033000_67.6.878.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057695"},{"key":"2026060105301033000_67.6.878.31","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(86)21067-8"},{"key":"2026060105301033000_67.6.878.32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/neuonc\/noae190","article-title":"Imaging PD-L1 in the brainjourney from the lab to the clinic","volume":"27","author":"Dar","year":"2025","journal-title":"Neuro Oncol."},{"key":"2026060105301033000_67.6.878.33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605642"},{"key":"2026060105301033000_67.6.878.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2010.12.011"},{"key":"2026060105301033000_67.6.878.35","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/annonc\/mdy423","article-title":"Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)","volume":"29","author":"Marabelle","year":"2018","journal-title":"Ann Oncol."},{"key":"2026060105301033000_67.6.878.36","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2021-1917"},{"key":"2026060105301033000_67.6.878.37","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1200\/JCO-25-01346","article-title":"RP1 combined with nivolumab in advanced anti-PD-1-failed melanoma (IGNYTE)","volume":"43","author":"Wong","year":"2025","journal-title":"J Clin Oncol."},{"key":"2026060105301033000_67.6.878.38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40336-021-00462-9","article-title":"Zr-PET imaging in humans: a systematic review","volume":"10","author":"De Feo","year":"2022","journal-title":"Clin Transl Imaging."},{"key":"2026060105301033000_67.6.878.39","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0280"},{"key":"2026060105301033000_67.6.878.40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2141"},{"key":"2026060105301033000_67.6.878.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18570-x"},{"key":"2026060105301033000_67.6.878.42","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jlcr.3628","article-title":"Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging","volume":"61","author":"Vivier","year":"2018","journal-title":"J Labelled Comp Radiopharm."},{"key":"2026060105301033000_67.6.878.43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13550-023-01059-1","article-title":"Performance and application of the total-body PET\/CT scanner: a literature review","volume":"14","author":"Sun","year":"2024","journal-title":"EJNMMI Res."},{"key":"2026060105301033000_67.6.878.44","doi-asserted-by":"crossref","unstructured":"Fransen MF Schoonderwoerd M Knopf P . Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight. 2018;3: e124507.","DOI":"10.1172\/jci.insight.124507"},{"key":"2026060105301033000_67.6.878.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.09.001"},{"key":"2026060105301033000_67.6.878.46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jha2.757","article-title":"PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphoma","volume":"4","author":"Ligero","year":"2023","journal-title":"EJHaem."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:58Z","timestamp":1785269938000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.2967\/jnumed.125.270922"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270922","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}